Agilent Technologies presented a Webinar back in March titled:
Uncover Epigenetic Signatures Faster using SureSelectXT Human Methyl-Seq
SureSelect is the most complete, flexible and proven Target Enrichment platform for Next Generation Sequencing. This presentation highlights features of the new SureSelect SureSelectXT Human Methyl-Seq kit including:
• Reduced bias compared to existing Methylation methods
• Comprehensive design for Methylation discovery
• High sensitivity with single base resolution
• Increased throughput, reduced cost
You can now replay the Webinar from the Agilent site.